Founded on the first and only platform designed to genetically engineer small molecule therapeutics from fungi and plants Led by veteran biotech executives Usman Azam, Chief Executive Officer, and Fred Grossman, Chief Medical Officer NEW YORK & CAMBRIDGE, England–( BUSINESS WIRE)–Empyrean Neuroscience, Inc., a leading genetic engineering company dedicated to developing neuroactive compounds to…


Previous articlePT365 – Dr. Jennifer Montjoy – KAP: Self-Agency Through Intention, Titration, and Ceremony
Next articleSilo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety Therapeutics